These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22565090)

  • 41. Cardiovascular and metabolic monitoring of children and adolescents on antipsychotic treatment: A cross-sectional descriptive study.
    de la Torre Villalobos M; Martin-López LM; Fernández Sanmartín MI; Pujals Altes E; Gasque Llopis S; Batlle Vila S; Pérez-Solá V; Novo Navarro P; Gómez Simón I; Fresno González C; Camprodon Rosanas E; Bulbena Vilarrasa A
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(1):19-26. PubMed ID: 27291832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antipsychotic medications: metabolic and cardiovascular risk.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of cardiovascular disease and sudden death in schizophrenia.
    Davidson M
    J Clin Psychiatry; 2002; 63 Suppl 9():5-11. PubMed ID: 12088174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse effects of antipsychotic medications.
    Muench J; Hamer AM
    Am Fam Physician; 2010 Mar; 81(5):617-22. PubMed ID: 20187598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
    Gury C; Canceil O; Iaria P
    Encephale; 2000; 26(6):62-72. PubMed ID: 11217540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.
    Brown CS; Farmer RG; Soberman JE; Eichner SF
    Clin Pharmacokinet; 2004; 43(1):33-56. PubMed ID: 14715050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antipsychotic drugs & their side effects.
    Jaco R
    Indian J Med Res; 2009 Feb; 129(2):208-9; author reply 209. PubMed ID: 19293453
    [No Abstract]   [Full Text] [Related]  

  • 49. Adverse effects of antipsychotic agents.
    Simpson GM; Pi EH; Sramek JJ
    Drugs; 1981 Feb; 21(2):138-51. PubMed ID: 6110535
    [No Abstract]   [Full Text] [Related]  

  • 50. Sudden death and antipsychotic drugs.
    Brown RP; Kocsis JH
    Hosp Community Psychiatry; 1984 May; 35(5):486-91. PubMed ID: 6144626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current and Novel Approaches to Mitigate Cardiometabolic Adverse Effects of Second-Generation Antipsychotics.
    Skonieczna-Żydecka K; Łoniewski I; Stachowska E; Marlicz W; Correll CU
    Int J Neuropsychopharmacol; 2020 Nov; 23(8):491-495. PubMed ID: 32239144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Metabolic disorders under antipsychotic treatment].
    Steffenhagen N; Rummel-Kluge C; Himmerich H
    Nervenarzt; 2012 Mar; 83(3):337-44. PubMed ID: 21206997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects.
    Siafis S; Tzachanis D; Samara M; Papazisis G
    Curr Neuropharmacol; 2018; 16(8):1210-1223. PubMed ID: 28676017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autonomic nervous system as a target for cardiovascular drugs.
    Bousquet P; Monassier L; Feldman J
    Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):446-8. PubMed ID: 9673821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Don't worry, be happy"--may be a first line therapy in cardiovascular diseases?
    Bălan H; Popescu L
    Rom J Intern Med; 2013; 51(2):73-9. PubMed ID: 24294809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ABC of poisoning. Cardiovascular, neurological, and other complications.
    Nielsen M; Henry J
    Br Med J (Clin Res Ed); 1984 Sep; 289(6446):681-6. PubMed ID: 6434040
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effects of phenothiazine derivatives on structures in the autonomic nervous system].
    BUDDE H; WITZLEB E
    Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):126-38. PubMed ID: 13239253
    [No Abstract]   [Full Text] [Related]  

  • 58. A hypothesized mechanism for the cardiovascular risk associated with antipsychotic drug exposure and a potential preventive treatment.
    Foley DL
    Mol Psychiatry; 2014 Jan; 19(1):12-3. PubMed ID: 23247075
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug-induced cardiovascular disorders.
    Murphy CA; Dargie HJ
    Drug Saf; 2007; 30(9):783-804. PubMed ID: 17722970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roles in and barriers to metabolic screening for people taking antipsychotic medications: a survey of psychiatrists.
    Parameswaran SG; Chang C; Swenson AK; Shumway M; Olfson M; Mangurian CV
    Schizophr Res; 2013 Feb; 143(2-3):395-6. PubMed ID: 23231879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.